Search results
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Is This a Setback for Moderna? | The Motley Fool
The Motley Fool· 20 hours agoInvestors have put their hopes in Moderna's (MRNA 2.64%) next potential product, a respiratory syncytial virus (RSV) vaccine. The RSV vaccine promises to...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 15 hours agoModerna stock tumbled — and then rebounded — after the Food and Drug Administration delayed its RSV...
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...
Simply Wall St. via Yahoo Finance· 6 days agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
Moderna director Noubar Afeyan sells over $1.8m in company stock By Investing.com
Investing.com· 4 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant amount of...
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
Zacks via Yahoo Finance· 2 days agoModerna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Cramer's Lightning Round: 'I'm a believer' in Moderna
CNBC· 8 hours ago"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to...
Moderna shares target raised to $85 by Deutsche Bank By Investing.com
Investing.com· 6 days agoOn Thursday, Deutsche Bank (ETR:DBKGn) revised its price target for Moderna (NASDAQ:MRNA) shares,...
Is Moderna Inc (MRNA) Set to Underperform? Analyzing the Factors
Guru Focus· 15 hours agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar | The Motley Fool
The Motley Fool· 2 days agoLet's consider two such stocks: Moderna (MRNA 7.13%) and DexCom (DXCM -1.65%). Moderna is one of the...